Dov Moran is a Managing Partner at Grove Ventures. He has made significant contributions to the healthcare industry, particularly in the realm of diabetes. As an investor and CEO of Glucomé Ltd., he plays a pivotal role in driving innovation and advancements in diabetes care. Glucomé Ltd. is a company focused on developing cutting-edge solutions and technologies to enhance the lives of individuals with diabetes. With Dov Moran at the helm, the company strives to provide innovative and practical tools that empower individuals to effectively manage their diabetes. As an investor, Dov Moran recognizes the potential of technology, including artificial intelligence, in transforming the landscape of diabetes management. Through his leadership, Glucomé Ltd. works on developing solutions that leverage AI to improve diabetes monitoring, treatment, and overall patient outcomes.